Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Redwood Pharma

Mindre end 1K følgere
Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Selskabsmeddelelse28.7.2024, 12.30

Redwood Pharma files for bankruptcy

Redwood Pharma
Selskabsmeddelelse26.6.2024, 09.00

Redwood Pharma provides a new update regarding divestment of company assets

Redwood Pharma
Pressemeddelelse12.6.2024, 10.00

Redwood Pharma provides an update on the process for divesting the company's assets

Redwood Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse23.5.2024, 11.00

Redwood Pharma provides an update on the company's future

Redwood Pharma
Pressemeddelelse8.5.2024, 06.30

Redwood Pharma's product RP501 attracted a lot of interest at ARVO in Seattle

Redwood Pharma
Pressemeddelelse7.5.2024, 06.30

Two international companies begin due diligence on Redwood Pharma's product RP501 ahead of potential commercial agreements

Redwood Pharma
Pressemeddelelse6.5.2024, 13.00

Redwood Pharma's board subscribes to units in the ongoing new issue

Redwood Pharma
Pressemeddelelse28.2.2024, 07.30

Redwood Pharma's innovative dry eye treatment to be presented at ARVO in Seattle

Redwood Pharma
Pressemeddelelse20.12.2023, 08.10

Redwood Pharma's CEO Martin Vidaeus in year-end interview

Redwood Pharma
Pressemeddelelse19.12.2023, 07.00

Redwood Pharma to participate in the JP Morgan Healthcare Conference

Redwood Pharma
Selskabsmeddelelse30.11.2023, 07.30

Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)

Redwood Pharma
Pressemeddelelse22.11.2023, 07.30

Redwood Pharma to participate in the NLS Days partner conference in Copenhagen

Redwood Pharma
Pressemeddelelse19.10.2023, 09.15

Redwood Pharma to participate in the BIO-Europe partnering conference in Munich

Redwood Pharma
Selskabsmeddelelse31.5.2023, 21.10

Redwood Pharma presents positive results from a clinical study with RP501 against dry eye

Redwood Pharma
Pressemeddelelse17.3.2023, 12.00

Redwood Pharma completes recruitment for clinical trial with RP501 for dry eye

Redwood Pharma
Pressemeddelelse24.1.2023, 07.30

Redwood Pharma takes important steps towards the commercial production of its dry eye product

Redwood Pharma
Selskabsmeddelelse15.12.2022, 16.00

Redwood Pharma enters partnership with Nextec medical in preparation for European market clearance of RP501

Redwood Pharma
Pressemeddelelse19.10.2022, 13.18

Interview with CEO Martin Vidaeus of Redwood Pharma at BioStock Investor Meeting, Stockholm

Redwood Pharma
Pressemeddelelse14.10.2022, 06.30

Redwood Pharma: Streamed video of CEO Martin Vidaeus presenting at Aktieportföljen Live in Stockholm, Sweden on Oct. 11, 2022

Redwood Pharma
Pressemeddelelse3.10.2022, 13.42

Redwood Pharma to present at AKTIEPORTFÖLJEN LIVE SVERIGE in Stockholm on 11[th] of Oct. 2022 at 14:45

Redwood Pharma
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.